- Home
- CNTB vs FBIO Comparison
CNTB vs FBIO Comparison
Compare CNTB & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- FBIO
- Stock Information
- Founded
- CNTB 2012
- FBIO 2006
- Country
- CNTB United States
- FBIO United States
- Employees
- CNTB N/A
- FBIO N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CNTB Health Care
- FBIO Health Care
- Exchange
- CNTB Nasdaq
- FBIO Nasdaq
- Market Cap
- CNTB 44.2M
- FBIO 49.1M
- IPO Year
- CNTB 2021
- FBIO N/A
- Fundamental
- Price
- CNTB $1.00
- FBIO $1.86
- Analyst Decision
- CNTB Strong Buy
- FBIO Strong Buy
- Analyst Count
- CNTB 2
- FBIO 2
- Target Price
- CNTB $7.50
- FBIO $21.00
- AVG Volume (30 Days)
- CNTB 93.6K
- FBIO 223.0K
- Earning Date
- CNTB 05-15-2025
- FBIO 08-12-2025
- Dividend Yield
- CNTB N/A
- FBIO N/A
- EPS Growth
- CNTB N/A
- FBIO N/A
- EPS
- CNTB N/A
- FBIO N/A
- Revenue
- CNTB $26,033,000.00
- FBIO $57,784,000.00
- Revenue This Year
- CNTB N/A
- FBIO $51.59
- Revenue Next Year
- CNTB N/A
- FBIO $44.74
- P/E Ratio
- CNTB N/A
- FBIO N/A
- Revenue Growth
- CNTB N/A
- FBIO N/A
- 52 Week Low
- CNTB $0.51
- FBIO $1.33
- 52 Week High
- CNTB $1.73
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- CNTB 59.56
- FBIO 51.19
- Support Level
- CNTB $0.91
- FBIO $1.70
- Resistance Level
- CNTB $1.12
- FBIO $2.15
- Average True Range (ATR)
- CNTB 0.08
- FBIO 0.11
- MACD
- CNTB 0.01
- FBIO -0.02
- Stochastic Oscillator
- CNTB 59.26
- FBIO 33.33
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.